Singapore markets closed

Coherus BioSciences, Inc. (CHRS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
11.47-0.57 (-4.73%)
At close: 04:00PM EST
11.50 +0.03 (+0.26%)
After hours: 04:14PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
363,599
475,824
356,071
0
Cost of revenue
57,160
37,667
17,078
-
Gross profit
306,439
438,157
338,993
-
Operating expenses
Research development
356,971
142,759
94,188
110,239
Selling general and administrative
157,354
139,079
137,037
94,177
Total operating expenses
514,325
281,838
231,225
204,416
Operating income or loss
-207,886
156,319
107,768
-204,416
Interest expense
22,837
21,166
17,601
9,684
Total other income/expenses net
108
554
2,608
4,691
Income before tax
-230,615
135,707
92,775
-209,409
Income tax expense
1,052
3,463
2,942
-
Income from continuing operations
-231,667
132,244
89,833
-209,409
Net income
-231,667
132,244
89,833
-209,339
Net income available to common shareholders
-231,667
132,244
89,833
-209,339
Basic EPS
-
1.85
1.29
-3.22
Diluted EPS
-
1.62
1.23
-3.22
Basic average shares
-
71,412
69,680
65,035
Diluted average shares
-
83,492
73,186
65,035
EBITDA
-
159,761
113,635
-196,490